ARCHIVES

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Antigenics Begins Phase II Trial Of Oncophage for NHL.

March 31, 2000

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

NCAB Approved NTP Transfer To NIEHS But Without Much Enthusiasm

May 30, 1980

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

In Brief: Indiana U. Planning “World Class” Cancer Center; UCLA Names Two New Cancer Control Directors

June 6, 1986

NCI To Use Technology Transfer Agreement To Privatize Journal In A Five-Year Deal

December 1, 1995